Bacteria are single-celled organisms that are extremely small. Although the majority of bacteria are harmless, some can infect people and cause diseases. A few have even been linked to the development of cancer. Apart from inducing cancer by interfering with the host's normal defense mechanisms such as inflammation and antigen recognition, some bacteria have been found to produce tumor proteins as a result of metabolic products, which have direct myogenic or mutagenic effects.
Despite the fact that traditional cancer treatments remain the most prominent, bacterial therapy has demonstrated significant results due to its high specificity, ability to control after ingestion, and presence in several live experiments. Because of its tumor selectivity and large gene packaging capability, bacteria targeting tumors is an ideal strategy to administer therapeutic treatments.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Spatial multi-omics inference of diabetes-triggered pancreatic cancer growth: The key role of cholesterol-induced neutrophil extracellular
Guanqun Li, The First Affiliated Hospital of Harbin Medical University, China
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada